Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labsystems Diagnostics is a global leader in neonatal screening and diagnostic solutions. Their products are used in over 70 countries for early detection of metabolic and genetic disorders in newborns as well as point-of-care testing for various clinical indications. The company has pioneered several technologies including the first microplate ELISA reader ("Multiskan") and continues to innovate with automated high-throughput systems like the NS2400 for neonatal screening. Their solutions are CE-marked and ISO 13485 certified[1][2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labsystems Diagnostics.